Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

J7626
HCPCS Code

2023 HCPCS
Billable/Valid Code

J7626 is a valid 2023 HCPCS Code that could be used to indicate Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg for reimbursement purposes.

J7626 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2007.

Short description for J7626 HCPCS code:

Budesonide non-comp unit

HCPCS J7626

J7626 code information

HCPCS code:	J7626
Description:	BUDESONIDE, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, UP TO 0.5 MG
Effective Date:	Jan 01, 2007
Added Date:	Jan 01, 2002
Termination Date:	HCPCS J7626 was terminated on Nov 30, -0001
Pricing indicator:	`51` - DRUGS
Multi Pricing indicator:	`A` - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY
Coverage code:	`C` - CARRIER JUDGMENT
BETOS code:	`D1G` -
Action code:	`N` - NO MAINTENANCE FOR THIS CODE
Type of Service:	`1` - MEDICAL CARE `P` - LUMP SUM PURCHASE OF DME, PROSTHETICS, ORTHOTICS
Anesthesia BUQ:	0